Alternative macrophage activation-associated transcripts in T-cell-mediated rejection of mouse kidney allografts

American Journal of Transplantation

Volumn 10, Issue 3, 2010, Pages 490-497

  Famulski, K S ^a,b   Kayser, D ^c   Einecke, G ^c   Allanach, K ^a   Badr, D ^a   Venner, J ^a   Sis, B ^a,b   Halloran, P F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Activins; Alternative macrophage activation; Cytokines; Inflammation; Kidney transplants inhibins; Macrophages; Mouse knockouts; Rejection; T cells; Transplantation

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; INHIBIN A; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; ACTIVIN; INHIBIN;

ACUTE KIDNEY TUBULE NECROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; HISTOPATHOLOGY; KIDNEY ALLOGRAFT REJECTION; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; ANIMAL; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; CBA MOUSE; CYTOLOGY; GRAFT REJECTION; KIDNEY TRANSPLANTATION; MACROPHAGE; METABOLISM; PROCEDURES; REPERFUSION INJURY; T LYMPHOCYTE;

ACTIVINS; ANIMALS; GRAFT REJECTION; INHIBINS; INTERLEUKIN-13; INTERLEUKIN-4; KIDNEY TRANSPLANTATION; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; MODELS, BIOLOGICAL; REPERFUSION INJURY; T-LYMPHOCYTES;

EID: 76949085022     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02983.x     Document Type: Article

References (47)

1. Magil AB. Monocytes/macrophages in renal allograft rejection. Transplant Rev (Orlando) 2009 23 : 199 208.
2. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005 5 : 953 964.
3. Segerer S, Heller F, Lindenmeyer MT et al. Compartment specific expression of dendritic cell markers in human glomerulonephritis. Kidney Int 2008 74 : 37 46.
4. Loverre A, Capobianco C, Stallone G et al. Ischemia-reperfusion injury-induced abnormal dendritic cell traffic in the transplanted kidney with delayed graft function. Kidney Int 2007 72 : 994 1003.
5. Barratt-Boyes SM, Thomson AW. Dendritic cells: Tools and targets for transplant tolerance. Am J Transplant 2005 5 : 2807 2813.
6. Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 2007 7 : 610 621.
7. Wyburn KR, Jose MD, Wu H, Atkins RC, Chadban SJ. The role of macrophages in allograft rejection. Transplant 2005 80 : 1641 1647.
8. Kluth DC, Erwig LP, Rees AJ. Multiple facets of macrophages in renal injury. Kidney Int 2004 66 : 542 557.
9. Ko GJ, Boo CS, Jo SK, Cho WY, Kim HK. Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion-induced acute kidney injury. Nephrol Dial Transplant 2008 23 : 842 852.
10. Mrug M, Zhou J, Woo Y et al. Overexpression of innate immune response genes in a model of recessive polycystic kidney disease. Kidney Int 2008 73 : 63 76. (Pubitemid 350273645)
11. Eardley KS, Zehnder D, Quinkler M et al. The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease. Kidney Int 2006 69 : 1189 1197.
12. Keepers TR, Gross LK, Obrig TG. Monocyte chemoattractant protein 1, macrophage inflammatory protein 1 alpha, and RANTES recruit macrophages to the kidney in a mouse model of hemolytic-uremic syndrome. Infect Immun 2007 75 : 1229 1236.
13. Girlanda R, Kleiner DE, Duan Z et al. Monocyte infiltration and kidney allograft dysfunction during acute rejection. Am J Transplant 2008 8 : 600 607.
14. Lefaucheur C, Nochy D, Hill GS et al. Determinants of poor graft outcome in patients with antibody-mediated acute rejection. Am J Transplant 2007 7 : 832 841.
15. Tinckam KJ, Djurdjev O, Magil AB. Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status. Kidney Int 2005 68 : 1866 1874.
16. Einecke G, Mengel M, Hidalgo LG, Allanach K, Famulski KS, Halloran PF. The early course of renal allograft rejection: Defining the time when rejection begins. Am J Transplant 2009 9 : 483 493.
17. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003 3 : 23 35.
18. Ogawa K, Funaba M, Chen Y, Tsujimoto M. Activin A functions as a Th2 cytokine in the promotion of the alternative activation of macrophages. J Immunol 2006 177 : 6787 6794.
19. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: An immunologic functional perspective. Annu Rev Immunol 2009, 27 : 451 483.
20. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008 8 : 958 969.
21. Wynn TA. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 2004 4 : 583 594.
22. Nair MG, Guild KJ, Artis D. Novel effector molecules in type 2 inflammation: Lessons drawn from helminth infection and allergy. J Immunol 2006 177 : 1393 1399.
23. Hardy CL, O'Connor AE, Yao J et al. Follistatin is a candidate endogenous negative regulator of activin A in experimental allergic asthma. Clin Exp Allergy 2006 36 : 941 950.
24. Lee E, Yook J, Haa K, Chang HW. Induction of Ym1/2 in mouse bone marrow-derived mast cells by IL-4 and identification of Ym1/2 in connective tissue type-like mast cells derived from bone marrow cells cultured with IL-4 and stem cell factor. Immunol Cell Biol 2005 83 : 468 474.
25. Lan YY, Wang Z, Raimondi G et al. "Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig. J Immunol 2006 177 : 5868 5877.
26. Famulski KS, Einecke G, Reeve J et al. Changes in the transcriptome in allograft rejection: IFN-g induced transcripts in mouse kidney allografts. Am J Transplant 2006 6 : 1342 1354.
27. Flechner SM, Kurian SM, Head SR et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 2004 4 : 1475 1489.
28. Mueller TF, Einecke G, Reeve J et al. Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant 2007 7 : 2712 2722.
29. Saint-Mezard P, Berthier CC, Zhang H et al. Analysis of independent microarray datasets of renal biopsies identifies a robust transcript signature of acute allograft rejection. Transplant Int 2009 22 : 293 302.
30. Sis B, Famulski KS, Allanach K, Zhu L-F, Halloran PF. IFN-g prevents early perforin-granzyme-mediated destruction of kidney allografts by inducing donor class I products in the kidney. Am J Transplant 2007 7 : 2301 2310.
31. Famulski KS, Sis B, Billesberger L, Halloran PF. Interferon-gamma; and donor MHC class I control alternative macrophage activation and activin expression in rejecting kidney allografts: A shift in the Th1-Th2 paradigm. Am J Transplant 2008 8 : 547 556.
32. Jabs WJ, Sedlmeyer A, Ramassar V et al. Heterogeneity in the evolution and mechanisms of the lesions of kidney allograft rejection in mice. Am J Transplant 2003 3 : 1501 1509.
33. Famulski KS, Broderick G, Hay K et al. Transcriptome analysis reveals heterogeneity in the injury response of kidney transplants. Am J Transplant 2007 7 : 2483 2495.
34. NobenTrauth N, Shultz LD, Brombacher F, Urban JF, Gu H, Paul WE. An interleukin 4 (IL-4)-independent pathway for CD4(+) T cell IL-4 production is revealed in IL-4 receptor-deficient mice. Proc Natl Acad Sci USA 1997 94 : 10838 10843.
35. Gentleman R, Carey VJ, Huber W, Irizarry R, Dudoit S. Bioinformatics and computational biology solutions using R and bioconductor. XII Ed. New York : Springer 2005.
36. Einecke G, Melk A, Ramassar V et al. Expression of CTL associated transcripts precedes the development of tubulitis in T-cell mediated kidney graft rejection. Am J Transplant 2005 5 : 1827 1836.
37. Einecke G, Broderick G, Sis B, Halloran PF. Early loss of renal transcripts in kidney allografts: Relationship to the development of histologic lesions and alloimmune effector mechanisms. Am J Transplant 2007 7 : 1121 1130.
38. Tavazoie S, Hughes JD, Campbell MJ, Cho RJ, Church GM. Systematic determination of genetic network architecture. Nat Genet 1999 22 : 281 285.
39. Reeve J, Einecke G, Mengel M et al. Diagnosing rejection in renal transplants: A comparison of molecular- and histopathology-based approaches. Am J Transplant 2009 9 : 1802 1810.
40. Rodriguez NE, Chang HK, Wilson ME. Novel program of macrophage gene expression induced by phagocytosis of Leishmania chagasi. Infection Immunity 2004 72 : 2111 2122.
41. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med 2003 197 : 1107 1117.
42. Florio P, Gazzolo D, Luisi S, Petraglia F. Activin a in brain injury. Adv Clin Chem 2007 43 : 117 130.
43. Donnelly S, Stack CM, O'Neill SM, Sayed AA, Williams DL, Dalton JP. Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages. FASEB J 2008 22 : 4022 4032.
44. Atochina O, Da'dara AA, Walker M, Harn DA. The immunomodulatory glycan LNFPIII initiates alternative activation of murine macrophages in vivo. Immunology 2008 125 : 111 121.
45. Weis N, Weigert A, von Knethen A, Brune B. Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants. Mol Biol Cell 2009 20 : 1280 1288.
46. Tiemessen MM, Jagger AL, Evans HG, van Herwijnen MJ, John S, Taams LS. CD4+CD25+Foxp3 +regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci USA 2007 104 : 19446 19451.
47. Wang Y, Wang YP, Zheng G et al. Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int 2007 72 : 290 299.